| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 08/01/2007 | CN1329508C Process method for producing HMG-CoA reductase inhibitor |
| 08/01/2007 | CN1329506C Recombinant bacterium with granular methane monooxygenase activity and application thereof |
| 08/01/2007 | CN1329504C A strain for producing composite enzyme and process for producing compoiste emzyme using said strain fermentation |
| 08/01/2007 | CN101010433A Biochemical synthesis of 1,4-butanediamine |
| 08/01/2007 | CN101010429A Alpha-amylase variants with altered properties |
| 08/01/2007 | CN101010428A Thymidine kinase |
| 08/01/2007 | CN101010425A C-terminal modification of polypeptides |
| 08/01/2007 | CN101010424A Improved methods of producing heterologous proteases |
| 08/01/2007 | CN101010423A L-glutamic acid-producing microorganism and a method for producing L-glutamic acid |
| 08/01/2007 | CN101010333A Purification of factor xiii polypeptides from biological materials |
| 08/01/2007 | CN101010331A Polypeptides having alpha-glucosidase activity and polynucleotides encoding same |
| 08/01/2007 | CN101008007A Alcohol dehydrogenase immobilization method |
| 08/01/2007 | CN101008005A Lucid ganoderma laccase preparation and production method thereof |
| 08/01/2007 | CN101007844A Synthetic peptides and methods for treating cancer invasion and metastasis |
| 08/01/2007 | CN101007840A Method for keeping activity of active protein under normal temperature |
| 07/31/2007 | US7251525 Treating or preventing arrhythmias in a human subject comprising the administration of an effective amount of a calcium/calmodulin-dependent protein kinase inhibitor. Also provided are pharmaceutical compositions as antiarrhythmia |
| 07/31/2007 | US7250561 Regulatory elements necessary for its transcription in plants and a coding sequence encoding an enzyme, hydroxyphenyl pyruvate dioxygenase, conferring on plants the tolerance to a herbicide |
| 07/31/2007 | US7250559 Nuclelotide sequences coding elongase (ELONG) and an enzyme involved in glucosinolate side-chain desaturation (ALK) for use as tools in controlling bitterness of plants; flavor enhance in crops |
| 07/31/2007 | US7250558 Disease resistance factors |
| 07/31/2007 | US7250557 Plastidic phosphoglucomutase genes |
| 07/31/2007 | US7250554 Precise breeding |
| 07/31/2007 | US7250504 Class II human histone deacetylases, and uses related thereto |
| 07/31/2007 | US7250503 Nucleic acid molecules encoding clot-specific streptokinase fusion proteins possessing altered plasminogen activation characteristics |
| 07/31/2007 | US7250502 Formaldehyde dehydrogenase genes from methylotrophic yeasts |
| 07/31/2007 | US7250495 PRO20044 polypeptides |
| 07/31/2007 | US7250492 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 07/31/2007 | US7250404 Lipid-mediated polynucleotide administration to deliver a biologically active peptide and to induce a cellular immune response |
| 07/31/2007 | US7250290 Arsenic methyltransferase sequence variants |
| 07/31/2007 | US7250285 Isolated nucleic acid; screening for antibacterial compounds |
| 07/31/2007 | US7250284 Destabilized bioluminescent proteins |
| 07/31/2007 | US7250283 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease |
| 07/31/2007 | US7250282 Isomaltulose synthases, polynucleotides encoding them and uses therefor |
| 07/31/2007 | US7250281 Subtilisin variants |
| 07/31/2007 | US7250280 Method of improving the production of biomass or a desired product from a cell |
| 07/31/2007 | US7250279 Human pyruvate dehydrogenese phosphatase |
| 07/31/2007 | US7250278 α-keto acid reductase, method for producing the same, and method for producing optically active α-hydroxy acids using the same |
| 07/31/2007 | US7250277 Protein which has an activity to produce raffinose from sucrose and galactinol |
| 07/31/2007 | US7250271 Anti-angiogenesis methods, compositions and uses therefor |
| 07/31/2007 | US7250269 Composition for assaying glycoprotein |
| 07/31/2007 | US7250268 Providing a cell which expresses an a fusion protein, contacting said cell with a test compound; determining whether test compound inhibits I kappa B kinase (IKK) activity |
| 07/31/2007 | US7250256 Its expression products can be used to provide reagents and methods for detecting neoplasia |
| 07/31/2007 | US7250250 Comprises nucleotide sequences coding proteins with plenty of SH3 domains (POSH) for preventing viral and bacterial infection and replication; rational drug design; viricides; antiapoptosis agents; bactericides |
| 07/31/2007 | US7250152 Supercritical fluids processing: preparation of protein microparticles and their stablilisation |
| 07/31/2007 | CA2331936C Proteins with changed epitopes and methods for the production thereof |
| 07/31/2007 | CA2295693C Mutant .alpha.-amylase having introduced therein a disulfide bond |
| 07/26/2007 | WO2007084808A2 Methods of preparing activated polymers having alpha nitrogen groups |
| 07/26/2007 | WO2007084630A2 Mutant jak3 kinase in human leukemia |
| 07/26/2007 | WO2007083274A1 Subsantially pure dermatan sulfate epimerase |
| 07/26/2007 | WO2007083100A2 Enzyme |
| 07/26/2007 | WO2007082482A1 Novel compound for treatment of tumor |
| 07/26/2007 | WO2007082402A2 Process for regioselective n(5)-formylation of (6s)-5,6,7,8-tetrahydropteroic acid and derivatives thereof |
| 07/26/2007 | WO2007067559A3 Antibacterial agents |
| 07/26/2007 | WO2007061918A3 In situ fructooligosaccharide production and sucrose reduction |
| 07/26/2007 | WO2007056604A3 Methods and compositions for modulating cell motility and inhibiting tumor metastasis |
| 07/26/2007 | WO2007048780A3 Nucleic acid molecules encoding phosphatidate cytidylyl-transferase-like polypeptides and methods of use |
| 07/26/2007 | WO2007046087A3 Pharmaceutical compositions and diagnostic methods for inflammatory skin disesaes, disorders or conditions |
| 07/26/2007 | WO2007039317A3 Plants having an increased content of amino sugars |
| 07/26/2007 | WO2007010133A3 Polypeptides having an activity in the mtbe degradation path and uses thereof |
| 07/26/2007 | WO2007008604A3 Single nucleotide polymorphisms associated with dose-dependent edema and methods of use thereof |
| 07/26/2007 | WO2007002031A3 Dna polymerase blends and mutant dna polymerases |
| 07/26/2007 | WO2006130527A3 Mutations and polymorphisms of fibroblast growth factor receptor 1 |
| 07/26/2007 | WO2006085934A3 Rab9 protein crystal structures and methods for identifying rab9 modulators |
| 07/26/2007 | WO2006024041A3 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 07/26/2007 | WO2004003175A3 Process and materials for production of glucosamine and n-acetylglucosamine |
| 07/26/2007 | WO2003088004A3 The cop protein design tool |
| 07/26/2007 | WO2003081210A3 Identification of kinase inhibitors |
| 07/26/2007 | WO2003062448A3 Sqv nucleic acids and polypeptides |
| 07/26/2007 | US20070174937 Plant having tolerance to environmental stress |
| 07/26/2007 | US20070174934 Method of selectively producing male or female sterile plants |
| 07/26/2007 | US20070174932 High amylose potato polysaccharide for use as renewable raw materials in food processing |
| 07/26/2007 | US20070174931 Methods for controlling gibberellin levels |
| 07/26/2007 | US20070174926 Sperm factor oscillogenin |
| 07/26/2007 | US20070174924 Transgenic mice containing TRP gene disruptions |
| 07/26/2007 | US20070173477 Polypeptides and nucleic acid molecules encoding the polypeptide; such molecules have use as probes for diagnosis of Alzheimer's disease, and for identification of compounds that modulate the activity of beta secretase |
| 07/26/2007 | US20070173468 Lymphoblast proteolytic enzyme which is secreted from human b lymphoblastic cells and recognizes and destroys bacterial DNA; bactericides |
| 07/26/2007 | US20070173431 Novel variant hypocrea jercorina CBH1 cellulases |
| 07/26/2007 | US20070173430 Composition comprising a lipase and a bleach catalyst |
| 07/26/2007 | US20070172936 Purified active HCV NS2/3 protease |
| 07/26/2007 | US20070172933 Thermally stable amidases |
| 07/26/2007 | US20070172928 Immunoglobulin chimeric monomer-dimer hybrids |
| 07/26/2007 | US20070172922 Secretion, transcription and sporulation genes in Bacillus clausii |
| 07/26/2007 | US20070172921 Secretion, transcription and sporulation genes in Bacillus clausii |
| 07/26/2007 | US20070172916 Novel bacillus 029cel cellulase |
| 07/26/2007 | US20070172915 Glycoprotein synthesis |
| 07/26/2007 | US20070172909 Non-ribosomal peptide synthetases and associated biosynthetic genes |
| 07/26/2007 | US20070172881 Expression vector comprising fungal gene sequences for use as tool in identifying antifungal polypeptides for use in treatment and prevention of fungal infection |
| 07/26/2007 | US20070172879 Thermophilic DNA polymerases from thermoactinomyces vulgaris |
| 07/26/2007 | US20070172868 Compositions for sequence determination using tagged polymerizing agents and tagged monomers |
| 07/26/2007 | US20070172867 Methods for sequence determination |
| 07/26/2007 | US20070172866 Methods for sequence determination using depolymerizing agent |
| 07/26/2007 | US20070172865 Sequence determination in confined regions |
| 07/26/2007 | US20070172864 Composition for sequence determination |
| 07/26/2007 | US20070172863 Compositions and methods for sequence determination |
| 07/26/2007 | US20070172862 Data stream determination |
| 07/26/2007 | US20070172861 Mutant polymerases |
| 07/26/2007 | US20070172858 Methods for sequence determination |
| 07/26/2007 | US20070172822 Prokaryotic dna repair ligases |
| 07/26/2007 | US20070172495 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 07/26/2007 | US20070172493 12832, a novel human kinase-like molecule and uses thereof |
| 07/26/2007 | US20070172485 Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics |